The Influence of Monoclonal Antibody Dose on Tumor Uptake of Radiolabeled Antibody

Richard L. Wahl, Monica Liebert, Barry S. Wilson

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


The impact of antibody protein dose on tumor accumulation of radiolabeled monoclonal antibody was studied in nude mice with xenografts of human melanomas. 225.28S, a murine monoclonal antibody reactive with a high-molecular weight antigen of melanoma, was radiolabeled with I-125 and administered intraperitoneally to nude mice with human melanoma xenografts. Three days later, the animals were sacrificed, and tumor and normal tissue uptake of I-125 antibody was determined. At doses of 6.25, 62.5, 625 and 1875 ug of monoclonal antibody, there were no significant differences in percent of injected dose reaching the tumor/g of tumor or in the non-tumor uptakes achieved. These findings indicate that in the melanoma system, antibody dose is not a critical determinant of tumor uptake, and additionally indicate that low doses of antibody protein are appropriate for studies involving radioiodinated antibody localization.

Original languageEnglish (US)
Pages (from-to)243-249
Number of pages7
JournalCancer Drug Delivery
Issue number4
StatePublished - 1986
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research


Dive into the research topics of 'The Influence of Monoclonal Antibody Dose on Tumor Uptake of Radiolabeled Antibody'. Together they form a unique fingerprint.

Cite this